T-cell Leukemia Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Leukemia Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating sorafenib tosylate in patients with recurrent aggressive non-Hodgkin lymphomas has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma [Phase 4]
A Phase 4 trial evaluating zidovudine, interferon alfa-2b, and PEG-interferon alfa-2b in HTLV-I-associated adult T-cell leukemia/lymphoma wa…
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy [EARLY_Phase 1]
A Phase 1 study evaluating the safety and tolerability of combining sirolimus with Hyper-CVAD chemotherapy in adults with lymphoid malignanc…
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma [Phase 1]
Phase 1 study evaluating the combination of bortezomib and azacitidine in adults with relapsed or refractory T-cell lymphomas; the trial is …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma [Phase 2]
A Phase 2 trial investigating 506U78 in patients with recurrent or refractory non-Hodgkin's lymphoma and T-cell lymphomas was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: 506U78 in Treating Patients With Lymphoma [Phase 2]
Phase 2 clinical trial update on the agent 506U78 for various lymphomas; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma [Phase 2]
A Phase II study of KW-0761 (mogamulizumab) in CCR4-positive adult T-cell leukemia-lymphoma has completed enrollment, with results posted in…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL [Phase 1]
Phase I study of KW-0761 (mogamulizumab) in relapsed CCR4-positive adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma; results ha…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas [EARLY_Phase 1]
An early-phase 1 study of lenalidomide in relapsed and/or refractory peripheral T-cell lymphomas was terminated.
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma [Phase 2]
Phase 2 clinical trial evaluating tipifarnib in relapsed or refractory lymphoma has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Evaluation of the MP Diagnostics HTLV Blot 2.4
Clinical trial update evaluating the MP Diagnostics HTLV Blot 2.4 diagnostic test for HTLV-1/HTLV-2 infections; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2011-08-22Clinical Trial Update: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) [Phase 4]
Phase 4 pilot study assessing the CHOP-daclizumab combination (CHOP-Zenapax) for HTLV-I-associated adult T-cell leukemia/lymphoma; the trial…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating Campath-1H (alemtuzumab) for adults with acute T-cell leukemia/lymphoma has completed, with results post…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac [Phase 1]
This is a completed Phase 1 trial evaluating a yttrium-90 radiolabeled anti-Tac antibody in patients with cutaneous T-cell lymphoma and adul…